Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Meta-analysis of the Placebo and Nocebo Effects Associated with Placebo Treatment in Randomized Trials of Lipid Lowering Therapy.

< BACK TO ARCHIVE


2022 Sep 15


Eur Heart J Qual Care Clin Outcomes


http://www.ncbi.nlm.nih.gov/pubmed/36107462?dopt=Abstract

Meta-analysis of the Placebo and Nocebo Effects Associated with Placebo Treatment in Randomized Trials of Lipid Lowering Therapy.

Authors

Meta-analysis of the Placebo and Nocebo Effects Associated with Placebo Treatment in Randomized Trials of Lipid Lowering Therapy.
Chin Y H, Lim O, Lin C, Chan Y Y, Kong G, Ng C H, Chong B, Syn N, Chan K E, Muthiah MD, Siddiqui M S, Wang J-W, Figtree G, Chan MY, Chew NWS
Eur Heart J Qual Care Clin Outcomes. 2022 Sep 15.
PMID: 36107462.

Abstract

Randomized controlled trials (RCTs) of lipid-lowering therapy (LLT) in which the control groups received placebo without background LLT offer unique insights into the placebo and nocebo effects of lipid-lowering RCTs.
Read This Paper